Management of elderly patients with head and neck cancer.
Ryo IshiiAkira OhkoshiNaomi KiyotaKazuto MatsuuraKoichi YasudaYoshinori ImamuraYuki SaitoAkihiro Hommanull nullPublished in: Japanese journal of clinical oncology (2022)
There are no established guidelines for managing older patients with head and neck cancer. Most clinical trials that define current standard therapy included few elderly patients. On the other hand, there is great variability in patients' comorbidities, physical functions, cognitive function, familial and financial background and values. The key point appears to be appropriate geriatric assessment, clarifying the patients' outcomes and a multidisciplinary team approach, including the treatment decision-making policy. Although these processes should be scientific in nature, the evidence for the treatment of elderly head and neck patients is very limited. This review summarizes the evidence available regarding the management of geriatric assessment, each treatment modality and the multidisciplinary team approach for older patients with head and neck cancers.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- clinical trial
- ejection fraction
- prognostic factors
- decision making
- randomized controlled trial
- physical activity
- stem cells
- public health
- type diabetes
- metabolic syndrome
- bone marrow
- early onset
- middle aged
- patient reported outcomes
- skeletal muscle
- replacement therapy